ABSTRACT G-protein-coupled receptor kinase 2 (GRK2) is a serine/ threonine kinase with an important function in the desensitization of G-protein-coupled receptors. Based on its ability to bind G-protein bg subunits as well as activated Ga q subunits, it can be considered as an effector for G-proteins. The recruitment of GRK2 to activated receptors is well known to be mediated by Gbg together with negatively charged membrane phospholipids. In the current study, we address the role of Ga q on the interaction of GRK2 with activated G q -protein-coupled receptors. Therefore, we established new Förster resonance energy transfer (FRET)-based assays to study the interaction of GRK2 with the M 3 -acetylcholine (M 3 -ACh) receptor as well as G q -protein subunits with high spatiotemporal resolution in single living human embryonic kidney 293T cells. M 3 -ACh receptor stimulation with 10 mM acetylcholine resulted in distinct changes in FRET, which reflects interaction of the respective proteins. GRK2 mutants with reduced binding affinity toward Ga q [GRK2(D110A)] and Gbg [GRK2(R587Q)] were used to determine the specific role of G q -protein-binding by GRK2. Comparison of absolute FRET amplitudes demonstrated that Ga q enhances the extent and stability of the GRK2-M 3 -ACh receptor interaction, and that not only Gbg but also Ga q can target GRK2 to the membrane. This reveals an important role of Ga q in efficient recruitment of GRK2 to M 3 -ACh receptors. Furthermore, interactions between Ga q and GRK2 were associated with a prolongation of the interaction between GRK2 and the M 3 -ACh receptor and enhanced arrestin recruitment by these receptors, indicating that Ga q influences signaling and desensitization.
Introduction
G-protein-coupled receptor kinases (GRKs) are a family of serine/threonine kinases that initiate the desensitization of G-protein-coupled receptors. By phosphorylating cytoplasmic regions of the receptor, they induce binding of arrestin proteins to activated receptors, resulting in an uncoupling of receptor signaling and initiation of receptor internalization (Krupnick and Benovic, 1998; Wu et al., 1998) . Most GRKs are ubiquitously expressed (Pitcher et al., 1998) , and alterations in their expression levels have been shown to be associated with several diseases, such as heart failure (Ungerer et al., 1993; Hata and Koch, 2003) . The important influence of GRKs in the cardiovascular system and other fields demonstrates that a comprehensive knowledge about the various functions of GRKs is of great interest.
Structurally, GRKs are multidomain proteins, containing an N-terminal RGS (regulator of G-protein signaling) homology domain, followed by a central kinase domain and a C-terminal domain (Pitcher et al., 1998) . The C-terminal domain is variable between the different GRKs, but in all cases is essential for their membrane targeting. GRK2 and GRK3 contain the largest C-terminal domain, including a pleckstrin homology domain that interacts with Gbg subunits as well as negatively charged membrane phospholipids Touhara et al., 1995) . Because of overlapping binding sites, these GRKs compete with inactive Ga q subunits for Gbg binding. Therefore, they only interact with Gbg and translocate to the membrane after G-protein activation (Ford et al., 1998) .
The RGS homology domain of GRK2 and GRK3 is known to interact with activated Ga q -proteins, but not with Ga s -or Ga i -proteins (Carman et al., 1999; Sallese et al., 2000) . It has been shown by a crystal structure that even a simultaneous binding of Gbg and Ga q is possible (Tesmer et al., 2005) . The GRK binding site on Ga q includes the Ga q switching region, which enables the discrimination between the active and inactive state of Ga q (Carman et al., 1999) . The GRK surface that binds Ga q (C-site) differs from the binding site RGS proteins use (A-site) (Zhong and Neubig, 2001; Sterne-Marr et al., 2003) , which is a possible explanation for the weak or complete lack of GAP (GTPase-activating protein) function of GRK2 (Carman et al., 1999) . The sequestration of activated G-protein subunits by GRK2 has been shown to desensitize the signaling of G-protein-coupled receptors independent of phosphorylation by preventing their interaction with downstream effectors (Raveh et al., 2010; Fernandez et al., 2011) . However, whether binding of activated Ga q affects the function of GRK2 is still unknown and needs further investigation.
With the present study, we aimed to clarify the effects of Ga q on the interaction of GRK2 with activated G q -proteincoupled receptors. Of special importance for our study were previously published GRK2 mutants with reduced binding affinity toward Ga q [GRK2(D110A)] (Sterne-Marr et al., 2003) and Gbg [GRK2(R587Q)] (Carman et al., 2000) . These mutants allowed determination of the individual contribution of the G q -protein subunits for the recruitment and interaction of GRK2 with G-protein-coupled receptors. We established new Förster resonance energy transfer (FRET)-based assays to study the interaction of GRK2 with the M 3 -acetylcholine (M 3 -ACh) receptor (M 3 -AChR) as well as G q -protein subunits with high spatiotemporal resolution in single living human embryonic kidney 293T (HEK293T) cells. Combining advantages of FRET imaging with the GRK2 mutants provided new insight into the influence of Ga q on extent and stability of GRK2 interaction with the M 3 -AChR.
Materials and Methods
Chemicals. Agar, ampicillin, enhanced chemiluminescence solution, and lysogeny broth were purchased from AppliChem (Darmstadt, Germany); acrylamide, glycine, MgCl 2 , milk powder, SDS, and tetramethylethylenediamine were from Carl Roth (Karlsruhe, Germany); agarose was from Biozym (Hessisch Oldendorf, Germany); CaCl 2 was from MERCK (Darmstadt, Germany); and Dulbecco's modified Eagle's medium, fetal calf serum, phosphate-buffered saline, penicillin/ streptomycin, L-glutamine, and trypsin-EDTA were from Biochrom (Berlin, Germany). All other substances were purchased from SigmaAldrich (Steinheim, Germany).
Plasmids. The M 3 -AChR was obtained from the Missouri S&T cDNA Resource Center (Rolla, MO). cDNAs for Ga q , Ga q -yellow fluorescent protein (YFP) (Hughes et al., 2001) , Gb 1 , Gg 2 , a 2A -adrenergic receptor (a 2A -AR), Ga i1 -YFP (C351I) (Bünemann et al., 2003) , Ga i1 (C351I) (Wise et al., 1997) , Ga o , Gb 1 -Cer (Frank et al., 2005) , M 3 -AChR-YFP (Hoffmann et al., 2012) , arrestin3-YFP (Krasel et al., 2005) , and GRK2 (Winstel et al., 1996) were described previously. M 3 -AChR-mTurquoise fluorescent protein (mTurq) was cloned analogously to M 3 -AChR-YFP. M 2 -AChR-cyan fluorescent protein (CFP) was generated by cloning CFP with a Ser-Arg linker to the C-terminus of human M 2 -AChR. GRK2-YFP and GRK2-mTurq were cloned by fusing the open reading frames of YFP and mTurquoise, respectively, to the C-terminus of human GRK2 using polymerase chain reaction. In these constructs, the last amino acid of GRK2 is connected to the second amino acid of the fluorescent protein by a Ser-Arg linker. The GRK2 mutants were generated from these plasmids by site-directed mutagenesis using the following primers: 59 CAAGATGTACGC-CATGAGGTGCCTGGACAAAAAG 39 (K220R), 59 CCGGGAGAT-CTTCGCCTCATACATCATG 39 (D110A), 59 CCTGTTCCCCAAC-CAGCTGGAGTGGCGGGGCG 39 (R587Q).
Cell Culture and Transfection. Experiments were performed in HEK293T cells cultured at 37°C in a humidified atmosphere with 5% CO 2 in Dulbecco's modified Eagle's medium (4.5 g/l glucose) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 units/ml penicillin, and 0.1 mg/ml streptomycin. Transient transfection was conducted with Qiagen Effectene Transfection Reagent (Qiagen, Hilden, Germany) according to the manufacturer's protocol. The general transfection protocol contained 0.5 mg M 3 -AChR, 1.6 mg Ga q , 0.5 mg Gb 1 , 0.2 mg Gg 2 , and 0.5 mg GRK2. In the experiments shown in Figs. 1, 4 , and 6, the protocol was adapted to 1 mg M 3 -AChR and 0.1 mg GRK2 to adjust the expression levels. Experiments were performed 40-48 hours after transfection at room temperature. Single-Cell FRET Imaging. FRET experiments were performed on an inverted fluorescence microscope (Eclipse Ti; Nikon, Düsseldorf, Germany) as described in Milde et al. (2013) . In some experiments, cells were not excited with the Lambda DG-4 (Sutter Instrument, Novato, CA) but with a light-emitting diode (LED) excitation system (pE-2; CoolLED, Andover, UK) containing LEDs emitting light at 425 and 500 nm, respectively. The intensity of both LEDs was set to 2%. All filters were unchanged. The recording interval is indicated in the figure legend of the respective experiment. Fluorescence data were corrected for background fluorescence, bleed-through, and false excitation, and the FRET ratio was determined as the quotient of the fluorescence intensities of YFP and CFP (F YFP /F CFP ). The data shown in Fig. 6A and Supplemental Figs. 3 and 4A were additionally corrected for bleaching effects. Individual FRET recordings were averaged and displayed either as absolute alterations in FRET ratio or as data normalized to the individual maximal agonist-induced response to compare onset and offset kinetics of the agonist-induced effect. Absolute alterations in FRET were determined as the difference between the averaged FRET ratio of the last 10 time points before stimulation with and withdrawal of the agonist for each individual recording. Monoexponential onset and offset kinetics were fitted with an exponential function for each individual recording. The obtained k values were used for further statistics. Biexponential kinetics was analyzed with the mean traces of the different conditions.
Quantification of Relative Expression Levels. Because of an influence on the extent of the FRET signal, the relative expression level of CFP and YFP was controlled. For calibration of the stoichiometry of the relative expression level, the construct YFP-b 2 -AR-CFP (Dorsch et al., 2009 ) and analogously cloned reference constructs with different fluorophores were used. Both fluorophores were excited individually, and fluorescence intensities were recorded and corrected for background fluorescence. The calibration factor was calculated as F CFP /F YFP . For each individual FRET recording, the factor F CFP /F YFP was calculated the same way. This factor was divided by the respective calibration factor to calculate the individual expression ratio.
For a reliable comparison of FRET signals, the relative expression ratio should not significantly differ between different conditions. An excess of the FRET acceptor YFP is advantageous, as an influence on the extent of the FRET signal is unlikely in that case.
Evaluation and Statistics. Data evaluation was conducted with Excel 2010 (Microsoft, Redmond, WA) and Origin Pro 9.1 (OriginLab, Northampton, MA). Arithmetic mean and standard error were calculated where applicable. Statistics were analyzed by analysis of variance (ANOVA) with Bonferroni post-hoc test. P ,0.05 were considered to represent significant differences between tested conditions.
Results
Interaction of GRK2 with M 3 -AChR. To study dynamics of GRK2 interaction with M 3 -AChR, we set out to image FRET between mTurq-labeled M 3 -AChR and YFP-labeled GRK2. Functionality of a similarly C-terminally labeled M 3 -AChR was described previously (Ziegler et al., 2011) . The C-terminally YFP-labeled GRK2 was functional, as it phosphorylated rhodopsin similarly to wild-type GRK2 (Supplemental Fig. 1 ). The fluorescently labeled constructs were transiently transfected in HEK293T cells and subjected to single-cell dual-emission FRET recording. mTurq was excited at 425 nm, and fluorescence of mTurq and YFP was recorded simultaneously, while cells were continuously superfused with buffer with or without agonist, allowing for determination of onset and offset kinetics as a function of agonist addition or withdrawal. Receptor stimulation with a saturating agonist concentration of ACh (10 mM) resulted in a reversible increase in YFP fluorescence (yellow trace) and a corresponding decrease in mTurq fluorescence (blue trace), reflecting the development of FRET due to the interaction between GRK2 and the M 3 -AChR (Fig. 1A) . The emission ratio of both recordings was determined as D(F YFP /F CFP ) and is referred to as FRET in the following paragraphs.
The kinase-deficient GRK2(K220R) (Kong et al., 1994) , which was used to control for effects due to receptor phosphorylation by GRK2, was comparable to wild-type GRK2 in FRET change (Fig. 1B) and agonist-mediated membrane translocation (Fig. 1C) . Therefore, a major influence of receptor phosphorylation on kinetics of GRK2-M 3 -AChR interactions can be excluded. To verify specificity of the agonist-dependent alteration of FRET, HEK293T cells were transfected with the same constructs, but additionally with unlabeled a 2A -AR and Ga i1 . GRK2 was recruited to the membrane after stimulation of a 2A -AR with 100 mM norepinephrine (Fig. 1C) . However, this membrane recruitment resulted in only a very minor development of "bystander" FRET between GRK2 and M 3 -AChR (Fig.  1B) , thereby confirming high specificity of the GRK2-M 3 -AChR interaction.
Interaction of GRK2 with Ga q and Gbg. The Ga q -protein binding-attenuated GRK2 variant GRK2(D110A) and the Gbg binding-attenuated GRK2(R587Q) were used to investigate the effect of Ga q and Gbg binding by GRK2 on the GRK2-M 3 -AChR interaction. To determine the effectiveness of the inserted point mutations, FRET-based interaction assays between GRK2 and Gbg or Ga q were established in HEK293T cells. M 3 -AChR stimulation with 10 mM ACh resulted in a reversible development of FRET that reflects Gbg-GRK2 and Ga q -GRK2 interaction (Fig. 2, A and B ). Between GRK2 and Ga i , only a minor rise in FRET was detectable, verifying specificity of the Ga q -GRK2 interaction (Supplemental Fig. 2A ). GRK2(R587Q) showed a small FRET signal with Gbg, and GRK2(D110A) showed a small FRET signal with Ga q , Fig. 1 . FRET imaging enables investigation of GRK2 recruitment to M 3 -AChR. (A) HEK293T cells transiently transfected with YFP-labeled GRK2, M 3 -AChR-mTurq, and unlabeled Ga q , Gb, and Gg were subjected to single-cell FRET imaging recorded at 2 Hz. mTurq was excited at 425 nm, and mTurq and YFP fluorescence were recorded simultaneously. M 3 -AChR stimulation with 10 mM ACh, as indicated by the black bar, resulted in a reversible increase in YFP fluorescence (yellow trace) and a corresponding decrease in CFP fluorescence (blue trace), reflecting the interaction between GRK2 and M 3 -AChR (lower panel). The FRET ratio was determined as D(F YFP / F CFP ) (upper panel). (B) Single-cell FRET recordings were averaged (mean 6 S.E.M.; n $ 12) and displayed as absolute alterations in FRET. Experiments with a 2A -AR [stimulated with 100 mM norepinephrine (NE)] and Ga i1 were used to control signal specificity. The absolute FRET amplitude of the underlying individual experiments was determined as described in the Materials and Methods section, and statistical analysis was performed by ANOVA with Bonferroni post-hoc test (*P , 0.05). (C) Images of the different conditions in the absence and presence of agonist (average of five sequential images recorded by live-cell confocal microscopy).
Ga q Effects on M 3 -ACh Receptor-GRK2 Interaction confirming that these mutants exhibit a substantially reduced affinity with respect to the binding of either Gbg or Ga q , or both (Fig. 2, C and D; Supplemental Fig. 2, B and C) . However, Ga q binding deficiency appeared not as potent as Gbg binding deficiency.
Furthermore, the FRET signal between Ga q and GRK2 (R587Q) was significantly diminished compared with wildtype GRK2, which confirms the importance of Gbg for GRK2 translocation. However, Ga q alone recruited a substantial amount of this mutant to the membrane, which argues in favor of a contribution of Ga q to GRK2 recruitment.
Onset kinetics of the changes in FRET was evaluated by monoexponential fitting. The FRET signal between GRK2 and Ga q (half time [t 1/2 ] 5 3.34 seconds) developed about 3 times slower than between GRK2 and Gbg (t 1/2 5 0.95 seconds) (Fig. 2E ). This suggests that membrane recruitment of GRK2 by Ga q is delayed compared with Gbg.
Monoexponential fitting did not reveal significant differences in dissociation kinetics of Gbg (t 1/2 5 25.1 seconds) and Ga q (t 1/2 5 27.1 seconds) from GRK2. However, the onset of Ga q dissociation was clearly delayed (Fig. 2F) , which argues in favor of a higher binding affinity of GRK2 to Ga q than to Gbg. Dissociation of Gbg was significantly accelerated with GRK2(D110A) (t 1/2 5 16.3 seconds), which suggests that Ga q binding affects interaction stability of GRK2 with Gbg.
Both Ga q and Gbg Recruit GRK2 to the Membrane. GRK2 membrane translocation was investigated by live-cell confocal microscopy with high temporal resolution. Representative examples demonstrated a clear agonist-dependent membrane targeting of GRK2, GRK2(D110A), and GRK2(R587Q) (Fig. 3A) . In contrast, the double mutant was barely targeted to the membrane. Statistical evaluation confirmed these observations ( Fig. 3B; Supplemental Fig. 2D ), suggesting that Ga q as well as Gbg can recruit GRK2 to the membrane.
Effects of Ga q Binding on GRK2-M 3 -AChR Interaction. Next we tested the contribution of Gbg, Ga q , and both together in the interaction of GRK2 with M 3 -AChR by means of FRET. Only a minor rise in FRET between M 3 -AChR and GRK2 was observed with the Gbg binding-attenuated GRK2 (R587Q) and GRK2(D110A 1 R587Q), confirming the importance of Gbg for GRK2 recruitment (Fig. 4A) . However, the FRET development was significantly diminished with the Ga q binding-attenuated GRK2(D110A) as well, which supports our hypothesis that Ga q is significantly involved in membrane Fig. 2 . Ga q binding by GRK2 is delayed compared with Gbg binding. HEK293T cells transiently transfected with Gb-Cer, GRK2-YFP, unlabeled M 3 -AChR, Ga q , and Gg for the Gbg-GRK2 interaction assay (A) and with Ga q -YFP, GRK2-mTurq, and unlabeled M 3 -AChR, Gb, and Gg for the Ga q -GRK2 interaction assay (B) were subjected to single-cell FRET imaging recorded at 2 Hz. M 3 -AChR stimulation with 10 mM ACh, as indicated, led to a development of FRET, reflecting the interaction of GRK2 with Gb and Ga q , respectively [representative recordings in (A) and (B)]. Individual single-cell FRET recordings were averaged (mean 6 S.E.M.; n $ 9) and displayed either as absolute alterations in FRET (C and D) or as data normalized to the individual maximal agonist-induced response to compare onset kinetics (E) and offset kinetics (F) of the agonist-induced effect. Statistics are given for analysis of absolute amplitudes or kinetics by ANOVA with Bonferroni post-hoc test (*P , 0.05).
targeting of GRK2. In this context, it was very important to exclude that the reduction in the amplitude of the FRET signal was due to unfavorable relative expression levels of the fluorescent proteins. Therefore, relative expression levels of GRK2 and M 3 -AChR were determined for each individual recording as described in the Materials and Methods section (Fig. 4B) . The results clearly showed that the observed differences in the amplitude of the FRET signal were not due to alterations in the relative expression levels of the fluorescent proteins.
We also compared onset kinetics and found no significant difference between wild-type GRK2 (t 1/2 5 1.44 seconds) and GRK2(D110A), but significantly slowed onset kinetics with GRK2(R587Q) (t 1/2 5 2.39 seconds) (Fig. 4C) . As GRK2(R587Q), unlike the others, is recruited to the receptor primarily by Ga q , these slowed kinetics correspond with the results of the GRK2-G-protein interaction assay that already hint at a delayed membrane targeting of GRK2 by Ga q compared with Gbg (Fig. 2E) . Gbg binding by GRK2(D110A) (t 1/2 5 1.21 seconds) occurred shortly before M 3 -AChR interaction of this mutant (t 1/2 5 1.76 seconds). Ga q binding by GRK2(R587Q) (t 1/2 5 2.79 seconds) was not significantly different from its M 3 -AChR interaction (t 1/2 5 2.39 seconds). These data suggest that GRK2 membrane translocation is the rate-limiting step for its receptor interaction.
Dissociation after withdrawal of the agonist proceeded with biphasic kinetics. An initial fast decline was followed by a slower phase that formed a major part (Fig. 4D) . This indicates that the majority of GRK2 receptor complexes exhibited a prolonged interaction. GRK2(R587Q) showed a delayed dissociation, which was comparable to the delayed dissociation of Ga q from GRK2. This suggests that, in the absence of Gbg binding, the dissociation of GRK2 from the receptor is mostly dependent on the dissociation from Ga q .
The role of Ga q in GRK2-M 3 -AChR interaction was further investigated in the same FRET assay without cotransfection of Ga q , Gbg, or the whole heterotrimer. The reduced FRET signal without overexpressed G q -proteins suggests that the endogenous G-proteins are not sufficient to effectively recruit the exogenous GRK2 to the exogenous receptors ( Fig. 4E;  Supplemental Fig. 2E ). Also, with overexpressed Ga q or Gbg, the development of FRET was diminished, which could argue that less functional G q -proteins were formed. Dissociation of GRK2 was significantly accelerated without overexpressed Ga q , suggesting that Ga q binding to GRK2 prolongs interaction of GRK2 with M 3 -AChR (Fig. 4F) .
Concentration-Response Curves. To determine the sensitivity of the GRK2 interactions, we measured concentrationresponse curves for Ga q -GRK2, Gbg-GRK2, and M 3 -AChR-GRK2 interactions under very similar conditions by utilizing the corresponding FRET assays (Fig. 5) . Interestingly, the highest sensitivity was observed for the interaction between Ga q and GRK2, which exhibited a concentration-response curve that was significantly left-shifted compared with the Gbg-GRK2 interaction. This argues in favor of a higher binding affinity between GRK2 and Ga q compared with GRK2 and Gbg, which was already suggested by the GRK2-G q -protein interaction assay (Fig. 2F) . The concentration-response curve of the Ga q Effects on M 3 -ACh Receptor-GRK2 Interaction M 3 -AChR-GRK2 interaction was further right-shifted, which can be attributed to the requirement of an active conformation of the receptor. This is known as the spare receptor phenomenon and corresponds well with the concentration-response curve of M 3 -AChR activation (Ziegler et al., 2011) .
Functional Effects of Ga q Binding by GRK2. To investigate, whether the effects of Ga q and Gbg on GRK2 recruitment influence GRK2 function, we analyzed the interaction of arrestin3 with the M 3 -ACh receptor by measuring FRET between arrestin3-YFP and M 3 -AChR-mTurq. Arrestin binding to G-protein-coupled receptors requires both GRK-induced receptor phosphorylation (Lohse et al., 1990) and agonist binding to the receptor (Krasel et al., 2005) . The latter study further describes that, upon agonist washout, the GRK2-induced receptor phosphorylation is more sustained than the arrestin binding to the receptor. For this reason, arrestin binds very rapidly to prephosphorylated receptors upon repeated stimulation. We confirmed this result with the M 3 -AChR and observed an accelerated arrestin recruitment during the second stimulation compared with the first stimulation ( Supplemental Fig. 3) . Accordingly, arrestin binding to the receptor reflects the GRK2-induced receptor phosphorylation, which demonstrates that real-time measurement of arrestin recruitment in response to agonist is a sensitive assay to study functionality of the different GRK2 mutants. Indeed, in the absence of overexpressed GRK2 or in the presence of the kinase-dead GRK2(K220R), the interaction of arrestin3 with the receptor was significantly reduced compared with wild-type GRK2 ( Fig. 6A; Supplemental Fig. 4A ). In these experiments, arrestin3 was always in excess of receptor (Supplemental Fig. 4B) , and equal expression of the GRK2 mutants was verified by western blotting (Supplemental Fig. 4C ). In the presence of the Gbg binding-attenuated and the GRK2 double mutant, arrestin binding was reduced to levels observed in the absence of overexpressed GRK2. This demonstrates that, although the Gbg binding-attenuated mutant is able to translocate to the membrane, binding of Gbg by GRK2 is required for receptor phosphorylation. Importantly, the interaction between receptor and arrestin was significantly diminished in the presence of Ga q binding-attenuated GRK2 mutant as well, suggesting that binding of Gbg and Ga q to GRK2 is required for full kinase function. Onset kinetics of the Fig. 4 . Ga q improves the extent and stability of agonist-dependent interaction of GRK2 with M 3 -AChR. Individual singlecell FRET recordings were averaged (mean 6 S.E.M.; n $ 12) and displayed either as absolute alterations in FRET (A) or as data normalized to the individual maximal agonist-induced response to compare onset kinetics (C) and offset kinetics (D) of the agonist-induced effect. The trace of wild-type (WT) GRK2 was already shown in Fig. 1B . Statistics are given for analysis of absolute amplitudes or kinetics by ANOVA with Bonferroni post-hoc test (*P , 0.05). (B) Relative expression levels of GRK2 mutants and M 3 -AChR in the assay shown in (A) were not significantly different between the conditions. (F) HEK293T cells transiently transfected analogously to (A), but without Ga q , Gbg, or the whole heterotrimer were subjected to single-cell FRET imaging recorded at 2 Hz. Individual singlecell FRET recordings were averaged (mean 6 S.E.M.; n $ 12) and displayed either as absolute alterations in FRET (E) or as data normalized to the individual maximal agonist-induced response to compare offset kinetics (F) of the agonist-induced effect.
arrestin binding to the M 3 -AChR appeared faster in the presence of wild-type GRK2 compared with the GRK2 mutants, although a detailed analysis was precluded by the increased noise due to the much-reduced amplitude in the context of the mutants. In all conditions, we observed a fast initial rise in the FRET signal, which presumably can be attributed to arrestin binding to prephosphorylated receptors. However, in cases where no functional GRK2 was expressed, the signal decreased subsequently to various degrees, probably due to competition with either G-proteins or even GRKs. Offset kinetics after withdrawal of the agonist was not significantly different between the conditions (t 1/2 5 2.82 seconds for GRK2), and was markedly faster than dissociation of GRK2 from the receptor.
Having demonstrated that Ga q binding to GRK2 contributes to functional GRK2-M 3 -ACh receptor interactions, we wondered whether it also affects interactions of GRK2 with G i -protein-coupled receptors. We therefore studied the interaction of GRK2 with the G i -protein-coupled M 2 -ACh receptor in the presence of the M 3 -ACh receptor and overexpressed G q -proteins. We found no significant difference between the receptor interaction of wild-type GRK2 and the Ga q binding-attenuated GRK2 mutant, which suggests that Ga q does not contribute to an increased GRK2 binding to G i -protein-coupled receptors ( Fig. 6B; Supplemental Fig. 4D ).
Discussion
In the present study, we investigated the contributions of Ga q and Gbg to the agonist-dependent interaction of GRK2 with G q -protein-coupled receptors and its function. For the first time, we were able to observe interactions between GRK2 and receptors or G-protein subunits in real time. Ga q contributed to GRK2 targeting to the membrane, enhanced the extent and stability of the interaction between GRK2 and the M 3 -AChR, and was important for maximal GRK2 function. These results were obtained from newly established FRET assays using GRK2 and GRK2 point mutants with impaired Ga q or Gbg interaction. Single-cell FRET imaging allowed resolving association and dissociation kinetics in response to fast application or withdrawal of agonist. The loss of function of the Ga q or Gbg binding-deficient GRK2 mutants used in this study was verified by FRET experiments (Fig. 2, C and  D) . Each of these mutants contains a point mutation which we consider unlikely to have a major effect on GRK2 interaction with the receptor, the respective unaffected G-protein subunit, or overall GRK2 folding. In addition, we controlled expression levels for each recording to ensure comparability of the FRET signals. Confocal imaging demonstrated that interaction of GRK2 with either Ga q or Gbg was sufficient for membrane targeting upon receptor stimulation (Fig. 3) . The role of Gbg is more prominent, which was reflected in faster Figs. 1 and 2 were subjected to single-cell FRET imaging recorded at 2 Hz. The M 3 -AChR was stimulated with increasing ACh concentrations, and the agonist-mediated responses were normalized to the saturating ACh concentration (mean 6 S.E.M.; n $ 9). Log(EC 50 ) of the underlying individual experiments was determined, and statistical analysis was performed by ANOVA with Bonferroni post-hoc test (*P , 0.05). Compared with Ga q -GRK2 interaction [log(EC 50 ) = 28.60 6 0.07, EC 50 = 2.52 nM ACh], the concentration-response curves of the Gbg-GRK2 interaction [log (EC 50 ) = 28.24 6 0.08, EC 50 = 5.82 nM ACh] and M 3 -AChR-GRK2 interaction [log (EC 50 ) = 27.14 6 0.09, EC 50 = 71.9 nM ACh] were significantly rightshifted. Fig. 6 . Functional effects of G q -protein binding to GRK2. (A) HEK293T cells transiently transfected with M 3 -AChR-mTurq, arrestin3-YFP, unlabeled Ga q , Gb, Gg, and the different GRK2 mutants were subjected to single-cell FRET imaging recorded at 5 Hz. Individual single-cell FRET recordings were corrected for bleaching, averaged (mean 6 S.E.M.; n $ 13), and displayed as absolute agonist-induced alterations in FRET. Statistics are given for analysis of absolute amplitudes by ANOVA with Bonferroni post-hoc test (*P , 0.05). (B) HEK293T cells transiently transfected with M 2 -AChR-CFP, GRK2-YFP, or GRK2(D110A), unlabeled M 3 -AChR, Ga q , Ga o, Gb, and Gg were subjected to single-cell FRET imaging recorded at 2 Hz. Individual single-cell FRET recordings were averaged (mean 6 S.E.M.; n $ 14) and displayed as absolute alterations in FRET. Statistics are given for analysis of absolute amplitudes or onset kinetics by ANOVA with Bonferroni post-hoc test (*P , 0.05).
interaction of GRK2 with Gbg than with Ga q (Fig. 2E) , and in a higher extent of FRET between GRK2 and the receptor for the Ga q binding-attenuated GRK2 mutant than the Gbg binding-attenuated mutant (Fig. 4A) . However, Ga q binding to GRK2 significantly enhanced the extent and stability of the GRK2-M 3 -AChR interaction. This was shown by the reduced receptor interaction of the Ga q binding-attenuated GRK2 compared with wild-type GRK2 (Fig. 4A) , and by the accelerated dissociation of GRK2 from M 3 -AChR after withdrawal of the agonist in the absence of Ga q (Fig. 4F) . However, the Ga q binding-attenuated GRK2(D110A) did not dissociate faster from M 3 -AChR than wild-type GRK2 (Fig. 4D) , which may be explained by the fact that this mutation only reduces the interaction between GRK2 and Ga q by about 70%. Furthermore, the affinity between GRK2 and Ga q seemed higher than between GRK2 and Gbg. This was suggested by delayed dissociation of Ga q from GRK2 compared with Gbg (Fig. 2F ) and a significantly higher sensitivity of the GRK2-Ga q interaction to increasing agonist concentrations compared to the GRK2-Gbg interaction (Fig. 5 ). This may suggest that the contribution of Ga q to GRK2 recruitment is higher at lower agonist concentrations. It has been previously shown that negatively charged phospholipids also play a role in the membrane targeting of GRK2 (Touhara, 1997) . Most likely, these charged phospholipids will work in concert with G-protein subunits to recruit GRK2 to membranes and receptors. However, we did not address this issue in the present study. The phospholipid binding sites on GRK2 have been mapped and do not overlap with either the Ga q or the Gbg binding site (Carman et al., 2000) .
It has been shown previously that both agonist occupancy and receptor phosphorylation are necessary for arrestin binding to G-protein-coupled receptors (Krasel et al., 2005) . Therefore, we used arrestin binding to the M 3 -AChR as a readout for receptor phosphorylation. Gbg binding was absolutely required for GRK2 function (Fig. 6A) , probably by placing GRK2 and the receptor in a favorable orientation as suggested by previous studies (Wu et al., 1998) . In the absence of Ga q binding, some GRK2 activity was retained. However, efficient arrestin recruitment to the M 3 -AChR was observed only in the context of interactions of GRK2 with both Ga q and Gbg. We therefore propose that simultaneous binding of GRK2 to Gbg and Ga q (Tesmer et al., 2005) brings GRK2 to a position where it can optimally phosphorylate the sites on the M 3 -AChR that are required for arrestin binding. Accordingly, we hypothesize that, dependent on binding of Ga q or Gbg or both, differential orientations or conformations of GRK2 in the receptor complex exist. In agreement with this hypothesis, we observed a delayed dissociation of the Gbg binding-attenuated GRK2 mutant from the receptor upon agonist washout (Fig. 4D) , which most likely was now dependent on the dissociation of Ga q from GRK2, which was similarly delayed (Fig. 2F) .
Comparing the dynamics of GRK2 and arrestin3 interactions with M 3 -AChRs, we found that surprisingly, the dissociation of arrestin from the receptor was much faster than the dissociation of GRK2 (Figs. 4A and 6A) . It is generally assumed that receptor phosphorylation does not affect receptor-G-protein coupling, and that receptor desensitization occurs only after binding of arrestins to the receptor (Lohse et al., 1992) . However, the prolonged interaction of GRK2 with the M 3 -AChR that we observed suggests that, at least for this receptor, G-protein-mediated signaling could already be inhibited by GRK2 binding. Hence, GRK2 presumably contributes to the phosphorylation-independent desensitization of receptor signaling that was previously attributed to the sequestration of Ga q and Gbg by GRK2 (Luo et al., 2008) .
Taken together, we could visualize interactions of GRK2 with G q -protein subunits and receptors in single cells and resolve detailed kinetics. Our results uncovered that Ga q binding to GRK2 enhances the recruitment of GRK2 to M 3 -ACh receptors. Ga q significantly prolongs the interaction of GRK2 with M 3 -AChR, leading to longer occupancy times of receptors, and improves GRK2 function, which likely contributes to altered signaling and desensitization of receptors.
